Automated Insulin Delivery Systems: Hopes and Expectations of Family Members.

Published

Journal Article

BACKGROUND:This study examines the hopes and expectations that children, adolescents, and adults with type 1 diabetes and their families have for new automated insulin delivery systems. The study also aims to examine how the automated insulin delivery system may impact family functioning and individual members' psychosocial adjustment. METHODS:Forty-eight semistructured focus groups (n = 195) and 89 individual interviews were conducted with children, adolescents, and adults with type 1 diabetes and parents and partners. Coders reviewed results in key themes most likely to contain references to the family system. Clusters were analyzed using thematic analysis to identify participants' salient hopes and expectations of how new technology may impact family relationships and individual psychosocial functioning. RESULTS:Three main themes emerged for participants' hopes and expectations for implementation of the automated insulin delivery system. First, there is an expectation that this diabetes technology will alleviate diabetes-specific worry and burden for the people with diabetes and other family members. Second, there is also hope that this system may reduce day-to-day stress and, third, improve family relationships. CONCLUSIONS:The unique perspective of a broad age group provides insight into how individuals and families creatively address the multiple tasks required in daily diabetes management. Study findings elucidate the very high hopes and expectations held by those managing type 1 diabetes and the impact this new technology may have on family relationships. Awareness of these hopes and expectations is important for developers and clinicians in addressing potential challenges to uptake and to ensure that expectations are set appropriately.

Full Text

Duke Authors

Cited Authors

  • Garza, KP; Jedraszko, A; Weil, LEG; Naranjo, D; Barnard, KD; Laffel, LMB; Hood, KK; Weissberg-Benchell, J

Published Date

  • March 2018

Published In

Volume / Issue

  • 20 / 3

Start / End Page

  • 222 - 228

PubMed ID

  • 29565721

Pubmed Central ID

  • 29565721

Electronic International Standard Serial Number (EISSN)

  • 1557-8593

International Standard Serial Number (ISSN)

  • 1520-9156

Digital Object Identifier (DOI)

  • 10.1089/dia.2017.0301

Language

  • eng